Complementary Roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in Medullary Thyroid Cancer-Reference-Cited by-同舟云学术

Complementary Roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in Medullary Thyroid Cancer

Published:2011-11-03 Issue:12 Volume:52 Page:1855-1863
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Kauhanen Saila,Schalin-Jäntti Camilla,Seppänen Marko,Kajander Sami,Virtanen Sami,Schildt Jukka,Lisinen Irina,Ahonen Aapo,Heiskanen Ilkka,Väisänen Mika,Arola Johanna,Korsoff Pirkko,Ebeling Tapani,Sane Timo,Minn Heikki,Välimäki Matti J.,Nuutila Pirjo

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference34 articles.

1. Medullary thyroid carcinoma

2. Prognostic factors in medullary thyroid carcinomas.Survival in relation to age, sex, stage, histology, immunocytochemistry, and DNA content

3. Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer

4. Pretargeted radioimmunotherapy in rapidly progressing, metastatic, medullary thyroid cancer

5. Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow-up of medullary thyroid carcinoma

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sensitivities evaluation of five radiopharmaceuticals in four common medullary thyroid carcinoma metastatic sites on PET/CT: a network meta-analysis and systematic review;Nuclear Medicine Communications;2023-09-29

2. PET/CT with various radiopharmaceuticals in the complex diagnosis of medullary thyroid carcinoma: a review;Diagnostic radiology and radiotherapy;2023-07-05

3. Acetate-Mediated Odorant Receptor OR51E2 Activation Results in Calcitonin Secretion in Parafollicular C-Cells: A Novel Diagnostic Target of Human Medullary Thyroid Cancer;Biomedicines;2023-06-11

4. Medullary Thyroid Cancer: Updates and Challenges;Endocrine Reviews;2023-05-19

5. Current perspectives on the management of patients with advanced RET-driven thyroid cancer in Europe;Frontiers in Oncology;2023-05-03